Christiane J Bruns is an expert in Surgery at University Hospital Cologne (Germany). As of August 2026, ScienceLeadR ranks Christiane J Bruns in the top 1% of experts worldwide for Esophageal Neoplasms, Esophageal Diseases and Pancreatic Neoplasms. Christiane J Bruns has authored 1,014 publications, the most recent in 2026, and is an investigator in 17 clinical trials, 3 of them ongoing. SLR score: 3,134 (community average: 125). How the SLR is computed.

LeadR Profile

Christiane J Bruns University Hospital Cologne Germany
3 134 ScienceLeadR Reputation 3134
Network Map

Surgery

Subspecialties: Oncology - Gastroenterology - Medical Imaging

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1992 - 2026

Source: PubMed

University of Cologne

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 1014

Citations

Citations: 21 048 1st author: 25 Last author: 353 Unique author: 24


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Sex-Specific Proteomic Profiling Identifies Pregnancy Zone Protein as a Complement-Linked Marker of Adverse Prognosis in Esophageal Adenocarcinoma.
PMID 42581747 — pregnancy, neoplasms, adenocarcinoma, survival analysis, proteomics, sex characteristics, sex, complement system proteins, prognosis, sex differences
Int J Cancer20260
[Management of complications of the upper gastrointestinal tract following external primary procedures : Case series on complex clinical courses and continuation of treatment at a high-volume center].
PMID 42573756 — gastrointestinal tract, upper gastrointestinal tract, therapeutics
Chirurgie (Heidelb)20260
Evaluation of ergonomics using the DEXTER ® Robotic Surgery System: the ERGODEX trial.
PMID 42545524 — ergonomics, research design, posture, surgeons
Surg Endosc20260
SMARCA2 and SMARCA4-deficiency is associated with a distinct molecular and microenvironmental subtype of esophageal adenocarcinoma.
PMID 42527418 — cells, immunohistochemistry, neoplasms, adenocarcinoma, chromatin, therapeutics, chromosomes, mast cells
Sci Rep20260
Clinical and prognostic significance of high-endothelial venule density in regional lymph nodes of esophageal adenocarcinoma.
PMID 42523584 — lymph nodes, neoplasms, adenocarcinoma, venules, lymph, neoadjuvant therapy, nivolumab, therapeutics, esophageal neoplasms, prognosis
Front Oncol20260

Clinical Studies 17

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 11
Phase 3 4
Phase 2 2

By status:

Completed 7
Unknown 5
Recruiting 3
Active not recruiting 1
Not yet recruiting 1

By type:

Interventional 11
Observational 6

By Monocentric/Multicentric:

monocentric 9
multicentric2to4 5
multicentric5to9 0
multicentricup10 3

Main Topics

Cohort/Consortium Investigators 7

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
External Beam Radiotherapy Combined With Endorectal High dose rate Brachytherapy in Elderly and Frail Patients With Rectal Cancer
NCT06729645 — radiotherapy, brachytherapy, neoplasms, aged, rectal neoplasms
N/ANot yet recruiting2026
Chemotherapy and Surgical Resection in Patients With Hepatic Oligometastatic Adenocarcinoma of the Pancreas
NCT04617457 — leucovorin, quality of life, pancreatic neoplasms, safety, neoplasms, adenocarcinoma, drug therapy, oxaliplatin, fluorouracil, pancreas, neoplasm metastasis, folic acid, levoleucovorin, laparotomy, irinotecan, chemotherapy
Phase 2Recruiting2021
CIRCULATing Biomarkers for Individualized Surgical Therapy in gastroEsophageal Cancer Phase 1
NCT04455282 — blood, esophagus, esophagogastric junction, neoplasms, biomarkers, therapeutics, esophageal neoplasms, veins
N/ARecruiting2021

LeadR Networks

Main global connection map